RESHAPING HUMAN MONOCLONAL-ANTIBODIES FOR IMAGING AND THERAPY

被引：0
|
作者：
VERHOEYEN, ME
SAUNDERS, JA
BRODERICK, EL
EIDA, SJ
BADLEY, RA
机构：
来源：
DISEASE MARKERS | 1991年 / 9卷 / 3-4期
关键词：
RESHAPING; HUMAN ANTIBODIES; IMAGING; THERAPY H17E2 PLAP HMFG1;
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Current problems in obtaining suitable monoclonal antibodies (MoAbs) for in vivo imaging and therapy can now be bypassed using protein-engineering rather than conventional hybridoma technology. Rodent antibody binding sites can be grafted onto human acceptor antibodies thus reshaping the human MoAbs into reagents with more desired specificities. We successfully exploited this technology to produce two reshaped human antibodies with the same specificities and very similar binding abilities as demonstrated for the mouse antibodies H17E2 and HMFG1.
引用
收藏
页码：197 / 203
页数：7
相关论文
共 50 条
  • [41] Immunoengineering in glioblastoma imaging and therapy
    Zanganeh, Steven
    Georgala, Petrina
    Corbo, Claudia
    Arabi, Leila
    Ho, Jim Q.
    Javdani, Najme
    Sepand, Mohammad R.
    Cruickshank, Kiara
    Campesato, Luis F.
    Weng, Chien-Huan
    Hemayat, Saeed
    Andreou, Chrysafis
    Alvim, Ricardo
    Hutter, Gregor
    Rafat, Marjan
    Mahmoudi, Morteza
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2019, 11 (06)
  • [42] Nanomaterials for cancer therapy and imaging
    Bae, Ki Hyun
    Chung, Hyun Jung
    Park, Tae Gwan
    MOLECULES AND CELLS, 2011, 31 (04) : 295 - 302
  • [43] A TECHNETIUM-LABELED MONOCLONAL-ANTIBODY FOR IMAGING METASTATIC MELANOMA
    FRYTAK, S
    CREAGAN, ET
    BROWN, ML
    SALK, D
    NELP, W
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (02): : 156 - 161
  • [44] Fluorophore-conjugated antibodies for imaging and resection of GI tumors
    Bouvet, Michael
    Hoffman, Robert M.
    MOLECULAR-GUIDED SURGERY: MOLECULES, DEVICES, AND APPLICATIONS II, 2016, 9696
  • [45] Nanotechnology for molecular imaging and targeted therapy
    Wickline, SA
    Lanza, GM
    CIRCULATION, 2003, 107 (08) : 1092 - 1095
  • [46] Targeted nanoparticles for imaging and therapy of endometriosis
    Slayden, Ov
    Luo, Fangzhou
    Park, Youngrong
    Moses, Abraham S.
    Demessie, Ananiya A.
    Singh, Prem
    Korzun, Tetiana
    Taratula, Olena
    Taratula, Oleh
    BIOLOGY OF REPRODUCTION, 2024, 110 (06) : 1191 - 1200
  • [47] A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing
    Roguska, MA
    Pedersen, JT
    Henry, AH
    Searle, SMJ
    Roja, CM
    Avery, B
    Hoffee, M
    Cook, S
    Lambert, JM
    Blattler, WA
    Rees, AR
    Guild, BC
    PROTEIN ENGINEERING, 1996, 9 (10): : 895 - 904
  • [48] Radiopharmaceuticals targeting PSMA for imaging and/or therapy
    Morgat, C.
    Gallerande, H. de Clermont
    Fernandez, P.
    Hindie, E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2019, 43 (03): : 284 - 286
  • [49] Biomedical applications of nanodiamonds in imaging and therapy
    Perevedentseva, Elena
    Lin, Yu-Chung
    Jani, Mona
    Cheng, Chia-Liang
    NANOMEDICINE, 2013, 8 (12) : 2041 - 2060
  • [50] The role of nanomedicine in the imaging and therapy of thrombosis
    McCarthy, Jason R.
    Jaffer, Farouc A.
    NANOMEDICINE, 2011, 6 (08) : 1291 - 1293
12345